Antimicrobial resistance in Neisseria gonorrhoeae.
暂无分享,去创建一个
[1] M. Chu,et al. Epidemiology of penicillin-resistant Neisseria gonorrhoeae isolated in Taiwan, 1960-1990. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[2] S. Morse,et al. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant , 1986, Antimicrobial Agents and Chemotherapy.
[3] F. Wignall,et al. In vitro antibiotic susceptibilities of Neisseria gonorrhoeae isolates in the Philippines , 1992, Antimicrobial Agents and Chemotherapy.
[4] D. Brown,et al. Antimicrobial susceptibility testing of Neisseria gonorrhoeae: a trial organised as part of the United Kingdom national external quality assessment scheme for microbiology. , 1988, Journal of clinical pathology.
[5] K. Holmes,et al. Localized outbreak of penicillinase-producing Neisseria gonorrhoeae. Paradigm for introduction and spread of gonorrhea in a community. , 1989, JAMA.
[6] M. Dessens-Kroon,et al. INCREASED TETRACYCLINE RESISTANCE IN GONOCOCCI IN THE NETHERLANDS , 1989, The Lancet.
[7] J. Dillon,et al. Beta-lactamase plasmids and chromosomally mediated antibiotic resistance in pathogenic Neisseria species. , 1989, Clinical Microbiology Reviews.
[8] I. Phillips,et al. Spectinomycin resistant gonococci. , 1983, British medical journal.
[9] V. Hemming,et al. PENICILUNASE-PRODUCING NEISSERIA GONORRHή , 1976, The Lancet.
[10] I Lind,et al. Epidemiology of antibiotic resistant Neisseria gonorrhoeae in industrialized and developing countries. , 1990, Scandinavian journal of infectious diseases. Supplementum.
[11] C. Thornsberry,et al. The National Gonorrhea Therapy Monitoring Study: I. Review of Treatment Results and of In‐vitro Antibiotic Susceptibility, 1972–1978 , 1979, Sexually transmitted diseases.
[12] F. Wignall,et al. ORAL ROSOXACIN FOR TREATMENT OF PENICILLIN-RESISTANT GONORRHOEA , 1984, The Lancet.
[13] I. Lind,et al. The Emergence of Penicillinase‐producing Neisseria gonorrhoeae Strains Carrying the 4.9 kb (Toronto) Plasmid in Denmark and of a Novel Large Plasmid in Two Nonpenicillinase‐producing Neisseria gonorrhoeae Strains , 1992, Sexually transmitted diseases.
[14] C. Ison,et al. Epidemiology of penicillin resistant Neisseria gonorrhoeae. , 1991, Genitourinary medicine.
[15] E. Hook,et al. Temporal Trends in Gonococcal Antibiotic Resistance in Baltimore , 1992, Sexually transmitted diseases.
[16] J. Zenilman,et al. Frequency and distribution in the United States of strains of Neisseria gonorrhoeae with plasmid-mediated, high-level resistance to tetracycline. , 1987, The Journal of infectious diseases.
[17] J. Dillon,et al. Effects of different media and methods of inoculum preparation on results of antimicrobial susceptibility testing of Neisseria gonorrhoeae by agar dilution , 1987, Antimicrobial Agents and Chemotherapy.
[18] K. Holmes,et al. Evaluation of Sampling Methods for Surveillance of Neisseria Gonorrhoeae Strain Populations , 1988 .
[19] C. Thornsberry,et al. SPECTINOMYCIN-RESISTANT PENICILLINASE-PRODUCING NEISSERIA GONORRHOEAE , 1981, The Lancet.
[20] C. Genco,et al. Acquisition of β-lactamase and TetM‐containing Conjugative Plasmids by Phenotypically Different Strains of Neisseria gonorrhoeae , 1990, Sexually transmitted diseases.
[21] M. W. Bentzon,et al. Spectinomycin hydrochloride (Trobicin) in the treatment of gonorrhoea. Observation of resistant strains of Neisseria gonorrhoeae. , 1973, The British journal of venereal diseases.
[22] P. Sparling,et al. A community-based outbreak of infection with penicillin-resistant Neisseria gonorrhoeae not producing penicillinase (chromosomally mediated resistance). , 1985, The New England journal of medicine.
[23] P. Murray,et al. Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeae. , 1990, Diagnostic microbiology and infectious disease.
[24] A. Meheus,et al. Epidemiology of sexually transmitted diseases: the global picture. , 1990, Bulletin of the World Health Organization.
[25] W. Shafer,et al. Identification of an envelope mutation (env-10) resulting in increased antibiotic susceptibility and pyocin resistance in a clinical isolate of Neisseria gonorrhoeae , 1984, Antimicrobial Agents and Chemotherapy.
[26] P. Murray,et al. Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline , 1989, Journal of clinical microbiology.
[27] Ian Phillips,et al. &bgr;-LACTAMASE-PRODUCING, PENICILLIN-RESISTANT GONOCOCCUS , 1976, The Lancet.
[28] C. Ison,et al. Sampling methods for monitoring changes in gonococcal populations , 1989, Epidemiology and Infection.
[29] J. Riou,et al. The epidemiology of Neisseria gonorrhoeae isolates in Dakar, Sénégal 1982-1986: antimicrobial resistance, auxotypes and plasmid profiles. , 1991, Genitourinary medicine.
[30] A. Evans,et al. Prolonged use of the Greenland method of treatment of gonorrhoea. , 1980, The British journal of venereal diseases.
[31] K. Kam,et al. Patterns of Antibiotic Susceptibility of Gonococci Isolated in Hong Kong, 1987–1990 , 1992, Sexually transmitted diseases.
[32] J. Tapsall,et al. Characteristics of Neisseria Gonorrhoeae Isolated in Australia Showing Decreased Sensitivity to Quinolone Antibiotics , 1992, Pathology.
[33] H. Handsfield,et al. A comparison of single-dose cefixime with ceftriaxone as treatment for uncomplicated gonorrhea. The Gonorrhea Treatment Study Group. , 1991, The New England journal of medicine.
[34] R. Willcox.. A survey of problems in the antibiotic treatment of gonorrhoea. With special reference to South-East Asia. , 1970, The British journal of venereal diseases.
[35] H. Heffernan,et al. Antibiotic susceptibilities, serotypes and auxotypes of Neisseria gonorrhoeae isolated in New Zealand. , 1992, Genitourinary medicine.
[36] P. Sparling,et al. Genetics of resistance in a non-beta-lactamase-producing gonococcus with relatively high-level penicillin resistance , 1986, Antimicrobial Agents and Chemotherapy.
[37] K. Quitzau,et al. Treating genitourinary and pharyngeal gonorrhoea with single dose ceftriaxone. , 1989, Genitourinary medicine.
[38] I. Lind. In-vitro susceptibility of Neisseria gonorrhoeae to thiamphenicol: results for selected groups of strains from different geographic areas and from different times. , 1984, Sexually transmitted diseases.
[39] E. Dunlop. GonorrhœA and the Sulphonamides* , 1949 .
[40] J. Pépin,et al. The dominance of a multiresistant strain of Neisseria gonorrhoeae among prostitutes and STD patients in The Gambia. , 1992, Genitourinary medicine.